Original Article. A study on the etiology of cirrhosis of liver in adults living in the Hills of Himachal Pradesh, India ABSTRACT

Similar documents
Jose D Sollano, MD Professor of Medicine University of Santo Tomas Manila, Philippines. University of Santo Tomas

Liver Cancer: Epidemiology and Health Disparities. Andrea Goldstein NP, MS, MPH Scientific Director Onyx Pharmaceuticals

EVALUATION OF ABNORMAL LIVER TESTS

Chronic Liver Disease: Etiological Spectrum in Adults

Liver Cancer Causes, Risk Factors, and Prevention

IS THERE A DIFFERENCE IN LIVER CANCER RATES IN PATIENTS WHO RECEIVE TREATMENT FOR HEPATITIS?

Abnormal LFTs in migrant populations. Dr Doug Macdonald Consultant Hepatologist Royal Free Hospital

JMSCR Volume 03 Issue 03 Page March 2015

A Review of Liver Function Tests. James Gray Gastroenterology Vancouver

Study of Lipid Profile Changes in Cirrhosis of Liver

Hepatocellular carcinoma in eastern India, a detail analytical report from a tertiary care hospital

Hepatocellular Carcinoma: Epidemiology and Screening

Risk Factors and Preventive Measures for Hepatocellular carcinoma (HCC) 울산의대울산대병원소화기내과박능화

Curriculum vitae. Doctorate in Medicine (in Gastroenterology), 1996, Post Graduate Institute of Medical Education & Research, Chandigarh

Prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus patients in a tertiary care hospital of Bihar

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries

HEPATOCELLULAR CARCINOMA: SCREENING, DIAGNOSIS, AND TREATMENT

Liver Cancer And Tumours

JMSCR Volume 03 Issue 01 Page January 2015

Fat, ballooning, plasma cells and a +ANA. Yikes! USCAP 2016 Evening Specialty Conference Cynthia Guy

Non-Alcoholic Fatty Liver Disease (NAFLD)

End Stage Liver Disease & Disease Specific Indications for Liver Transplant. Susan Kang, RN, MSN, ANP-BC

End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC

What Is Cirrhosis? CIRRHOSIS. Cirrhosis occurs when the liver is. by chronic conditions and diseases. permanently scarred or injured

Are we adequately screening at-risk patients for hepatocellular carcinoma in the outpatient setting?

Diseases of liver. Dr. Mohamed. A. Mahdi 4/2/2019. Mob:

PROGRAMME AT A GLANCE

World Health Organization. Western Pacific Region

Investigations before OLT, Immunosuppression and rejection, Follow up after OLT.

STOP Hepatocellular Carcinoma

UMHS-PUHSC JOINT INSTITUTE

Hepatocellular carcinoma in Sri Lanka - where do we stand?

Seroprevalence and risk factors in blood-borne viral hepatitis cases attending a tertiary care hospital in Lucknow

Autoimmune Hepatitis Events Easl

Patterns of abnormal LFTs and their differential diagnosis

Disclosure. Evaluation of Abnormal Hepatic Enzymes

Hepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary)

Cirrhosis of the Liver

Why to biopsy? Indications for liver biopsy in common medical liver diseases- how are they changing?

Patterns of abnormal LFTs and their differential diagnosis

Pharmacologyonline 2: 3-7 (2011) Case Report Singhal et al.

2. Liver blood tests and what they mean p2 Acute and chronic liver screen

Primary Care Approach to Diagnosis and Management of Chronic Hepatitis C Brian Viviano, D.O.

2. Liver blood tests and what they mean p2 Acute and chronic liver screen

Assessment of NAFLD cases and its correlation to BMI and metabolic syndrome in healthy blood donors in Kerman

American Journal of Oral Medicine and Radiology

Hepatology For The Nonhepatologist

Hepatitis. Dr. Mohamed. A. Mahdi 5/2/2019. Mob:

Chewing the Fat on Fatty Liver Mike Kolber MD, CCFP, MSc PEIP 2018

Dr David Rowbotham NHS. The Leeds Teaching Hospitals. NHS Trust

Hepatocellular Carcinoma (HCC)

Transplant Hepatology

The impact of the treatment of HCV in developing Hepatocellular Carcinoma

Liver Pathology in the 0bese

Patients With Diabetes and Chronic Liver Disease Are at Increased Risk for Overall Mortality: A Population Study From the United States

LIVER DISORDERS (PRACTICAL MANAGEMENT) Dr Pok Kern (PK) TAN Gastroenterologist Calvary hospital, ACT 1 st April 2017

Changing epidemiology of HCC in Italy

Tumor incidence varies significantly, depending on geographical location.

Screening for HCCwho,

Clinical Management of Hepatitis B WAN-CHENG CHOW DEPARTMENT OF GASTROENTEROLOGY & HEPATOLOGY SINGAPORE GENERAL HOSPITAL

Liver transplant: what is left after the viruses

Learning Objectives. After attending this presentation, participants will be able to:

Update on Nonalcoholic Fatty Liver Disease. Kathleen E Corey, MD, MPH, MMSc Director, Mass General Fatty Liver Clinic

SEROPREVALENCE OF ANTI-HCV ANTIBODIES AMONG VOLUNTARY BLOOD DONORS IN FATEHABAD DISTRICT OF HARYANA

Hepatitis in healthcare workers (HCWs)

Int. J. Pharm. Sci. Rev. Res., 46(1), September - October 2017; Article No. 07, Pages: 37-41

Healthy Liver Cirrhosis

Seroprevalence of Hepatitis B Surface Antigen (HBsAg) Among Patients at a Tertiary Care Hospital in Mumbai, India

Media centre. WHO Hepatitis B. Key facts. 1 of :12 AM.

Transient elastography in chronic viral liver diseases

Assessment of Liver Stiffness by Transient Elastography in Diabetics with Fatty Liver A Single Center Cross Sectional observational Study

Non-Alcoholic Fatty Liver Diseasean underestimated epidemic

Improving Access to Quality Medical Care Webinar Series

Evaluation of Reasons of Pre- Blood Donor Deferrals: A Retrospective Study at a Tertiary Care Teaching Hospital

DISCHARGE DIAGNOSES OF LIVER DISEASES IN NUUK GREENLAND COMPARED TO A DANISH COUNTY HOSPITAL

Normal ALT for men 30 IU/L 36% US males abnormal. Abnl ALT. Assess alcohol use/meds. Recheck in 6-8 weeks. still pos

Complications Requiring Hospital Admission and Causes of In-Hospital Death over Time in Alcoholic and Nonalcoholic Cirrhosis Patients

Hepatocellular carcinoma

Understanding Liver Disease

Research Article Changes in Etiologies of Hospitalized Patients with Liver Cirrhosis in Beijing 302 Hospital from 2002 to 2013

Approach to the Patient with Abnormal Liver Enzymes

Original Research Article. Shanker Suman 1 *, Divya Jyoti 2, Pramod Kumar Agrawal 1, Bijoy Kumar Bhattacharya 2

Kalagara Pavani*, Srinivas Rao MS, Vinayaraj EV, Manick Dass

Hepatitis E in developing countries

Hepatocytes produce. Proteins Clotting factors Hormones. Bile Flow

4/26/2017. Liver Transplant and Palliative Care: Teaming up to improve care

A Preliminary Study on the Safety and Efficacy of HD-03/ES Therapy in Patients with Chronic Hepatitis B

Spring 2017 Health & Wellness Seminar Series. Seminar 1: April 25 th, 2017

Cryptogenic Cirrhosis: An Approach To The Diagnosis In The Era Of Molecular and Genomic Medicine

EAST LONDON INTEGRATED CARE

Esophageal Varices Beta-Blockers or Band Ligation. Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph

Hepatocellular Carcinoma. Markus Heim Basel

Risk Factors of Hepatitis B Infection Among Patients In Tertiary Care Hospital, Kurnool

CITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE

Screening cardiac patients for advanced liver disease

ABNORMAL LIVER FUNCTION TESTS. Dr Uthayanan Chelvaratnam Hepatology Consultant North Bristol NHS Trust

Module 1 Introduction of hepatitis

SEROLOGICAL STATUS OF HEPATITIS B VIRUS INFECTION AMONG MONKS AND NOVICES AT BUDDHIST MONASTERIES IN THREE TOWNSHIPS, YANGON

HEPAMAP: A ROADMAP FOR HEPATOLOGY RESEARCH IN EUROPE: AN OVERVIEW FOR POLICY MAKERS

Prevalence study of hypertension among adults in an urban area of Jammu

Transcription:

37 Original Article Department of Gastroenterology, Indra Gandhi medical College, Shimla, HP, 2 Department of Medicine Kangra H.P. India, 3 Department of Medicine, 4 Department of physiology Corresponding author*: Dr. Sujeet Raina C-5, Type-5 residences, Dr. RPGMC Campus, Tanda, Kangra (HP), India-7600 email: sujeetrashmishera@ yahoo.co.in A study on the etiology of cirrhosis of liver in adults living in the Hills of Himachal Pradesh, India Brij Sharma, Rishab Marwah 3, Sujeet Raina 2*, Neetu Sharma 4, Madan Kaushik 3, Satinder Singh Kaushal 3 ABSTRACT Aim: Cirrhosis of the liver is an important cause of morbidity and mortality in India. Currently no study exists on the disease from Himachal Pradesh, India. The purpose of this study was to evaluate epidemiological data on the etiological profile of cirrhosis of the liver in adults in a tertiary care hospital in a northern hilly state of Western Himalayas. Materials & Methods: A hospital based, cross sectional, observational study was conducted in the department of Medicine and Gastroenterology in a tertiary care centre of Himachal Pradesh, located in northern India from st June, 202 to 3 st May, 203. In total, 78 patients who were diagnosed with cirrhosis on the basis of history, physical examination, biochemistry and radiology, and of age >8 years were included in the study. Detailed history, examination and investigations were carried out in each case as per protocol. Results: Alcohol was the leading cause of cirrhosis in our study (62.9%), hepatitis B was the second(0.%), Non-Alcoholic Steatohepatitis (NASH) was the third (7.9%), and autoimmune the fourth (3.9%) most common cause for cirrhosis. Hepatitis C was present in 2.8% of patients as a cause of cirrhosis. Wilson disease and cardiac cirrhosis were present in one patient each. In 9.6% the etiology was cryptogenic. Conclusion: The study identified alcohol as the leading cause of cirrhosis among people in the state. Measures for taking care of preventable risk factors are desired. KEYWORDS: Cirrhosis, Etiology, India, alcohol Introduction The etiological spectrum of cirrhosis has varied among different geographical populations worldwide. Countries where alcohol consumption is high have reported it as the leading cause of cirrhosis, whereas countries where alcohol consumption is low or prohibited have showed viral hepatitis as the most common cause of cirrhosis. Tropical Gastroenterology 206

38 A systematic review of 8 studies including 23,797 patients showed alcohol (46%) as the leading cause of cirrhosis followed by hepatitis C (35%), hepatitis B (%) and other causes (2%). 2 In India as well the cause of cirrhosis has varied among different studies. In an earlier study, hepatitis B was found to be the leading cause of cirrhosis in the young (50.8%) as well as in adults(44.3%) followed by alcohol in the young(5.9%) and in adults(35.8%). 3 Regional variation has also been observed from the study done on 75 patients with chronic liver disease in eastern India. It showed hepatitis B (35.4%), hepatitis C (4.9%), autoimmunity (2.8%), Wilson s disease (2.8%) and alcohol (.7%) as causes of cirrhosis. No etiology could be found in 5.8% patients. 4 A study done in eastern Madhya Pradesh also reported their etiological spectrum for chronic liver disease with hepatitis B (40.6%) as the most common cause for cirrhosis followed by alcohol (33.3%), hepatitis C (3.3%), and Non Alcoholic Fatty Liver disease or NAFLD (2.2%). No etiology could be found in 9.4 % cases. 5 In 200, there were an estimated 88,575 liver cirrhosis deaths in India, accounting for almost one-fifth (8.3%) of the global liver cirrhosis death toll. 6 Epidemiological data on the etiological aspects of cirrhosis of the liver are insufficient and have not yet been reported from Himachal Pradesh. Therefore, this study was planned and conducted in a tertiary care hospital providing gastroenterology services in Himachal Pradesh, India located in the Western Himalayas. This study is the first of its kind from this region. Materials and methods This cross sectional, observational study was conducted in a tertiary care centre in Himachal Pradesh, located in northern India from st June, 202 to 3 st May, 203. All admitted patients who were diagnosed with cirrhosis on the basis of history, physical examination, biochemistry and radiology and of age >8 years were included in the study. Patients on immunosuppressants and unwilling to participate in the study were excluded. A detailed history was taken and a questionnaire was administered. The questionnaire enquired into various risk factors which included the following: history of alcohol consumption including amount and duration, CAGE score, history of blood transfusions, surgeries, needle prick injury, past history of jaundice and high-risk sexual behavior. A detailed clinical examination was performed and recorded in a proforma. For each patient, the following laboratory parameters were measured: haemogram, liver function tests, renal function tests and blood glucose. Viral markers like HBsAg and anti- HCV antibody by immunochromatographic rapid card test were done in each patient. Ascitic fluid biochemistry and cytology were done in every patient with ascites. Serological markers like antinuclear antibodies (ANA), antibody against liverkidney-microsomes (LKM), antismooth muscle antibodies (ASMA) and IgA ttg antibody were done in patients who were nonalcoholic and negative for viral markers. Serum ceruloplasmin, urinary copper levels and slit lamp examination for Kayser-Fleischer ring was done in young cirrhotics (< 40 years), who were nonalcoholic and negative for viral markers. All obese patients, in whom other etiologies of cirrhosis were ruled out, non-alcoholic steatohepatitis(nash) was considered as the possible cause for cirrhosis. Ultrasound abdomen was done in all patients, followed by computed tomography if ultrasound was inconclusive or if there was evidence of hepatocellular carcinoma. Upper gastrointestinal endoscopy was performed in all patients unless contraindications like hemodyanamic instability, encephalopathy or respiratory failure were present. The study was approved by the institutional ethics committee. Results The study included a total of 78 patients; 24 (69.7%) were males and 54 (30.3%) were females. The male to female ratio was 2.3:. The age group of the study population ranged from 8 years to 98 years. A total of 5 (64.6%) patients were in the age group of 40-59 years. Mean age was 5.2 years. The causes of cirrhosis observed along with their frequencies are as shown in Table. The frequency distribution of etiology according to age and sex are shown in Table and Table 2 respectively. Alcohol as the cause for cirrhosis was present across all age groups with a majority of patients falling in the age group 40-59 years(74.%). Alcohol was the leading cause of cirrhosis in males and it was

A study on the etiology of cirrhosis of liver in adults living in the Hills of Himachal Pradesh 39 Table : Etiology and age distribution Age Alcohol Hep B Hep C NASH Auto Immune Wilson Cardiac Cryptogenic 8 29 2 0 0 0 0 4 0 30 39 8 3 0 0 0 0 0 2 0 40 49 42 3 2 2 2 0 0 3 0 50 59 4 5 3 6 3 0 0 3 0 60 69 7 5 0 4 2 0 2 3 70 2 0 2 0 0 0 3 0 Celiac disease Total 2 (62.9%) 8 (0.%) 5 (2.8%) 4 (7.9%) 7 (3.9%) 7 (9.6%) 3 (.7%) Table 2: Etiology and sex distribution Sex Alcohol Hep B Hep C NASH Auto Immune Wilson Cardiac Cryptogenic Celiac disease Male 06 (94.6%) (6.%) 2 (40%) 4 (28.6%) 0 0 0 (5.9%) 0 Female 6 (5.4%) 7 (38.9%) 3 (60%) 0 (7.4%) 7 (00%) (00%) (00%) 6(94.%) 3(00%) Total 2 (62.9%) 8 (0.%) 5 (2.8%) 4 (7.9%) 7 (3.9%) 7 (9.6%) 3(.7%) seen in 06 males out of 24 male patients (85.4%) while NASH and autoimmune as causes of cirrhosis were more common among females. Out of 8 patients with hepatitis B, 8 patients were also alcoholic. In our study, alcohol consumption was higher among males, with 56.6% males consuming > 60g/day while among females 50% consumed less than 80g/day as shown in Figure. Majority of the patients (72.6%) had been consuming alcohol for the previous 0-20 years and 26.4% patients had been consuming it for more than 20 years. 8 patients (0.%) were overweight and 0.% patients were obese, in whom NASH was considered to be the possible cause for cirrhosis. Figure : Discussion Pictogram showing a relation between quantity of alcohol consumed with duration

40 Liver cirrhosis is largely preventable. Identifying and subsequently controlling the risk factors for cirrhosis have been recognized. The various etiologies of cirrhosis are alcohol, hepatitis B, hepatitis C, autoimmune, NASH, biliary cirrhosis, cardiac cirrhosis, inherited metabolic liver diseases including hemochromatosis, Wilson s disease, α antitrypsin deficiency and finally cryptogenic cirrhosis for which no underlying cause has been identified. In India, mortality due to liver cirrhosis increased from 77,74 (95% uncertainty levels 52,96-6,746) in 980 to 88,575 (95% uncertainty levels 09,748-303,989) in 200. 6 Alcohol was the leading cause of cirrhosis in our study (62.9%), hepatitis B was the second (0.%), nonalcoholic steatohepatitis(nash) was the third (7.9%) and autoimmune the fourth (3.9%) most common cause of cirrhosis. Hepatitis C was present in 2.8% of patients as a cause of cirrhosis. Wilson disease and cardiac cirrhosis were present in one patient each. In 9.6% the etiology was cryptogenic. Among studies done in India it has been found that HBV (35-49%) is the leading cause of cirrhosis. 3-5 A study done by Sarin et al showed HBV (44.3%) followed by alcohol (35.8%) as the leading causes of cirrhosis in adults. 3 A study done in eastern Madhya Pradesh also reported their etiological spectrum for chronic liver disease with hepatitis B (40.6%) as the most common cause for cirrhosis followed by alcohol (33.3%), hepatitis C (3.3%), NAFLD (2.2%), and cryptogenic (9.4%). 5 Another study done in eastern India showed hepatitis B (35.4%), hepatitis C (4.9%), autoimmunity (2.8%), Wilson s disease (2.8%) and alcohol (.7%) as causes of cirrhosis. 6 In India, the recorded alcohol per capita (5+ age in years) consumption (in liters of pure alcohol) was 4.3 in 200 as reported by the WHO. In 202, the age standardized death rates(asdr), as per WHO, due to liver cirrhosis in India among males and females were 39.5 and 9.6 respectively, out of which alcohol attributable fractions(aaf) constituted 62.9% and 33.2% respectively. 7 According to the alcohol atlas of India, the prevalence of alcohol use among men in Himachal Pradesh is between 25-49%. 8 Consumption of liquor is perceived to be a part of the social and religious lives of the tribal population of Himachal Pradesh. 9 It is evident from this study that regular, moderate alcohol consumption in middle age males is the dominant cause of cirrhosis in this part of world. From analyzing the second most common cause of cirrhosis in our study, it can be established that India is considered to have an intermediate level of hepatitis B virus (HBV) endemicity with 3.7% point prevalence, that is, over 40 million HBV carriers. 0 The prevalence of HBV estimated in Himachal Pradesh is 0.536 (CI 0.35-0.937). NASH was the third most common cause of cirrhosis in our study. Metabolic syndrome has emerged as a significant health concern as was observed in the newly diagnosed hypertensive patients in the state, reflecting the epidemiological transition experienced in this hilly region. 2 Autoimmunity as the cause of cirrhosis was found exclusively among females in our study as all 7 patients of autoimmune etiology were female. Autoimmune hepatitis occurs more commonly in females. 3 Hepatitis C is not a common cause of cirrhosis in this region possibly because of low prevalence in the area As the population prevalence of HCV infection in India is % 0 and a study has shown a relative absence of HCV infection in Shimla. 4 South Asia, particularly India, requires priority attention to improve prevention and control of liver cirrhosis risk factors, considering that almost one fifth (8.3%) of global liver cirrhosis deaths in 200 occurred in India alone. 6 Mortality as a result of cirrhosis has been steadily increasing in India since 980, as has alcohol consumption. There has also been an increase in the prevalence of hepatitis B and C and diabetes (a major risk factor for nonalcoholic fatty liver disease (NAFLD). The favourable points of this study are that the causes of cirrhosis in this region were identified, which help us in predicting complications and to direct treatment decisions. Knowledge of the common causes also allows discussing their preventive measures. Focus on primary prevention by abstaining from alcohol consumption, preventive hepatitis B vaccination and adopting a healthy life style are the measures recommended. References:. Schuppan D, Afdhal NH. Liver Cirrhosis. Lancet. 2008 Mar 8;37(965):838 5.

A study on the etiology of cirrhosis of liver in adults living in the Hills of Himachal Pradesh 4 2. D Amico G, Garcia Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: A systemic review of 8 studies. J Hepatol 2006; 44:27-3 3. SK Sarin, S Chari, KR Sundaram, RK Ahuja, BS Anand, SL Broor. Young v adult cirrhotics: a prospective, comparative analysis of the clinical profile, natural course and survival. Gut 988; 29:0-07 4. Ray G, Ghoshal UC, Banerjee PK, Pal BB, Dhar K, Pal AK et al. Aetiological spectrum of chronic liver disease in eastern India. Trop Gastroenterol. 2000; 2:60-62 5. Trimukhe R, Rai R, Narayankar SM, Shewale S, Jagtap N, Rai S et al. Epidemiological spectrum of chronic liver disease in eastern Madhya Pradesh India. J Assoc Physicians India 20;59:48 6. Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J et al. Liver cirrhosis mortality in 87 countries between 980 and 200: a systematic analysis. BMC Medicine 204;2:45. 7. WHO Global status on alcohol and health 204. Available from: www.who.int/substance_abuse/ publications/global_alcohol_report/en/[last accessed on 07-2-204] 8. Alcohol atlas of India. Available from: www. indianalcoholpolicy.org/alcohol_atlas.html[last accessed on 07-2-204] 9. Romila B, Rakesh G, Mai C, Chauhan JK. Alcoholism a social evil among the tribals of Kinnaur district of Himachal Pradesh. Journal of Farm Sciences 20;: 37-44. 0. NCDCNewsletter204;JanMar,vol3.Availablefrom:http:// ncdc.gov.in/writereaddata/linkimages/newsltr003 2046680274026.pdf[Last accessed on 07-2-204]. Batham A, Gupta MA, Rastogi P,Garg Sreenivas V, Puliyel JM. Calculating prevalence of Hepatitis B in India: Using population weights to look for publication bias in conventional meta-analysis. Indian J Pediatr 2009;76:247-57 2. Thakur S, Raina S, Thakur S, Negi PC, Verma BS. Prevalence of metabolic syndrome among newly diagnosed hypertensive patients in the hills of Himachal Pradesh, India. Indian J Endocr Metab 203;7:723-26 3. Krawitt, E.L. Autoimmune hepatitis. N Engl J Med 996; 334: 897-903 4. Ganju SA, Goel A. Hepatitis C virus activity in Shimla-A preliminary report. Indian J Med Microbiol 200; 9:227.